These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33345449)

  • 21. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
    Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
    Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
    Synold TW; Relling MV; Boyett JM; Rivera GK; Sandlund JT; Mahmoud H; Crist WM; Pui CH; Evans WE
    J Clin Invest; 1994 Nov; 94(5):1996-2001. PubMed ID: 7525652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype.
    Demina I; Zerkalenkova E; Illarionova O; Olshanskaya Y; Verzhbitskaya T; Semchenkova A; Tsaur G; Rusanova E; Belogurova M; Baidun L; Plyasunova S; Konyuhova T; Kazakova A; Fechina L; Novichkova G; Samochatova E; Myakova N; Maschan A; Popov AM
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2803-2811. PubMed ID: 31463716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma?
    Li S; Lew G
    Arch Pathol Lab Med; 2003 Oct; 127(10):1340-4. PubMed ID: 14521459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Static cytometry identifies hyperdiploid childhood ALL.
    van den Berghe JA; Chen YC; Zhang Y; Kueh YK; Lee SH
    Cancer Genet Cytogenet; 2000 Dec; 123(2):123-7. PubMed ID: 11156737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Ploidy and S-phase Fraction Analysis in Paediatric B-cell Acute Lymphoblastic Leukemia Cases: a Tertiary Care Centre Experience.
    Kumar BK; Bhatia P; Trehan A; Singh AP; Kaul D; Bansal D
    Asian Pac J Cancer Prev; 2015; 16(17):7917-22. PubMed ID: 26625821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA index and karyotype in childhood lymphoblastic leukemia.
    Forestier E; Holmgren G; Roos G
    Anal Cell Pathol; 1998; 17(3):145-56. PubMed ID: 10221329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
    Schumich A; Maurer-Granofszky M; Attarbaschi A; Pötschger U; Buldini B; Gaipa G; Karawajew L; Printz D; Ratei R; Conter V; Schrappe M; Mann G; Basso G; Dworzak MN;
    Pediatr Blood Cancer; 2019 May; 66(5):e27590. PubMed ID: 30561169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Whitehead VM; Payment C; Cooley L; Lauer SJ; Mahoney DH; Shuster JJ; Vuchich MJ; Bernstein ML; Look AT; Pullen DJ; Camitta B
    Leukemia; 2001 Jul; 15(7):1081-8. PubMed ID: 11455977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
    Brun E; Tennvall J; Baldetorp B; Kjellén E; Fallenius G; Wennerberg J
    Acta Otolaryngol; 2004 Aug; 124(6):712-9. PubMed ID: 15515496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country.
    Anane E; Lakhal FB; Salem SF; Ghali O; Feki E; Abdennebi YB; Bahri M; Azza E; Aissaoui L; El Borgi W; Gouider E
    Cytometry B Clin Cytom; 2024 Sep; 106(5):405-411. PubMed ID: 38708886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High resolution Chromosomal Microarray Analysis (CMA) enhances the genetic profile of pediatric B-cell Acute Lymphoblastic Leukemia patients.
    Mitrakos A; Kattamis A; Katsibardi K; Papadhimitriou S; Kitsiou-Tzeli S; Kanavakis E; Tzetis M
    Leuk Res; 2019 Aug; 83():106177. PubMed ID: 31261022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of tumoral ploidy in a series of spanish patients with acute lymphoblastic leukemia.
    Ramos ML; Palacios JJ; Fournier BG; Martínez JL; Martinez-López J; Conde MC; Izquierdo AM; García MM; Miranda EB
    Cancer Genet Cytogenet; 2000 Oct; 122(2):124-30. PubMed ID: 11106823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric DNA index, G-band karyotyping, and comparative genomic hybridization in detection of high hyperdiploidy in childhood acute lymphoblastic leukemia.
    Nygaard U; Larsen J; Kristensen TD; Wesenberg F; Jonsson OG; Carlsen NT; Forestier E; Kirchhoff M; Larsen JK; Schmiegelow K; Christensen IJ
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):134-40. PubMed ID: 16679935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
    Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
    Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
    Reiter M; Diem M; Schumich A; Maurer-Granofszky M; Karawajew L; Rossi JG; Ratei R; Groeneveld-Krentz S; Sajaroff EO; Suhendra S; Kampel M; Dworzak MN;
    Cytometry A; 2019 Sep; 95(9):966-975. PubMed ID: 31282025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.
    Gudapati P; Khanka T; Chatterjee G; Ghogale S; Badrinath Y; Deshpande N; Patil J; Narula G; Shetty D; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2020 Jul; 98(4):328-335. PubMed ID: 31944572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.